Kymera Therapeutics (KYMR)
(Real Time Quote from BATS)
$43.37 USD
-1.63 (-3.62%)
Updated Oct 3, 2024 03:45 PM ET
After-Market: $43.01 -0.36 (-0.83%) 4:06 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Earnings News For KYMR
-
Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report?
-
Kymera (KYMR) Q2 Loss Narrower Than Expected, Pipeline in Focus
-
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates
-
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
-
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: Should You Buy?
-
Will Kymera Therapeutics, Inc. (KYMR) Report Negative Q3 Earnings? What You Should Know
-
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Misses Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Lags Revenue Estimates
-
Analysts Estimate Kymera Therapeutics, Inc. (KYMR) to Report a Decline in Earnings: What to Look Out for
-
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Lags Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Tops Revenue Estimates
-
Kymera Therapeutics, Inc. (KYMR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release